Intrahepatic Cholangiocarcinoma

Total Page:16

File Type:pdf, Size:1020Kb

Intrahepatic Cholangiocarcinoma 54) BY Prof Dr. Ahmed Al_Gebaly Case 1 54 Male Admitted with distended abdomen and vomiting. Case 2 Patient Data Male 47 years complaining Difficulty in swallowing liquids. Case 3 C/O: Recurrent chest infection Case 4 Axial contrast enhanced CT image of child with jaundice. Case 5 73 year old male with Jaundice Case 1 54 Male Admitted with distended abdomen and vomiting. Grossly distended stomach, containing a large volume of debris. Thickening and enhancement of the anturm/pylorus of the stomach, suggesting of a tumour Stenosing tumour, which caused the gastric outlet obstruction. Biopsy - proven adenocarcinoma. Gastric outlet obstruction is a syndrome resulting from mechanical obstruction of stomach emptying. an be due to malignant or benign causes. Malignant adenocarcinoma (second most common) GIST lymphoma (less commonly than other malignancies as it is a "soft" tumour) metastases Benign duodenal or gastric peptic ulcers (most common) pancreatic pseudocysts gastric varices granulomatous disease, e.g. Crohn disease, sarcoidosis, tuberculosis gallstones (Bouveret's syndrome): rare strictures, e.g. from caustic substance ingestion Gastric adenocarcinoma, commonly referred to as gastric cancer, refers to a primary malignancy arising from the gastric epithelium. It is the most common gastric malignancy (over 95% of malignant tumours of the stomach). Gastric cancer is rare before the age of 40 It often produces no specific symptoms such as dyspepsia. Patients may present with anorexia and weight loss (95%) as well as abdominal pain that is vague and insidious in nature. Nausea and vomiting, may occur (with bulky tumours that obstruct the gastrointestinal lumen or infiltrative lesions that impair stomach distension); late signs. CT is currently the staging modality of choice because it can help identify the primary tumour, assess for the local spread, and detect nodal involvement and distant metastases . Demonstration of lesions facilitated by negative contrast agents (water or gas): a polypoid mass with or without ulceration focal wall thickening with mucosal irregularity or focal infiltration of the wall ulceration: gas-filled ulcer crater within the mass infiltrating carcinoma: wall thickening and loss of normal rugal fold pattern 4 Calcifications are rare but when present, they are usually mucinous adenocarcinoma. There are several nodal metastases with eponymous names associated with gastric cancer has been described: sister Mary Joseph’s node Virchow’s node Krukenberg’s node Sister Mary Joseph (born Julia Dempsey, 1856-1939) was the surgical assistant to William Mayo in the early days of the Mayo ClinicA Sister Mary Joseph nodule is a metastatic lesion involving the umbilicus. The most common primary source is an intra-abdominal adenocarcinoma (include the stomach, ovary, colon and pancreas). solid subcutaneous or dermal nodule or focal umbilical thickening, generally in the context of widespread malignancy. For a lesion involving the umbilicus consider paraumbilical hernia surgical scar (e.g. laparoscopy) endometriosis granuloma primary umbilical tumour Metastasis to the umbilicus, known as a Sister Mary Joseph nodule, in a patient with metastatic ovarian cancer T of the abdomen and pelvis obtained with oral and intravenous contrast demonstrates a focal thickening of the sigmoid colon with stenosis of the lumen but no evidence of an established obstruction. No clear fat plane between the mass and the rectus muscle is identified although there is no convincing evidence of direct extension. A number of enlarged local lymph nodes are seen in the adjacent mesentery. No convincingly enlarged retroperitoneal nodes are noted, however an umbilical nodule is present. The liver contains a number of low attenuation ill-defined lesion, the largest in segment 5. Simple left renal cyst noted. Lungs and mediastinum appear unremarkable (although lung windows should of course be reviewed for small deposits). This case unfortunately demonstrates advanced colorectal carcinoma (pathologically proven well differentiated adenocarcinoma) in a young patient. It should act as a reminder that although typical age-range is a great way of limiting a differential diagnosis, most pathologies are sometimes encountered well outside the expected age groups and as such age alone is not enough to discount a diagnosis. Double-contrast barium enema demonstrates a focal narrowing in the sigmoid colon. It has rolled, heaped up shoulders and results in a severe stenosis. Features are typical of the so-called apple-core stenosis. The remainder of the imaged colon appears normal in calibre, and lined by normal mucosa. Troisier sign Troisier sign is the clinical finding of a hard and enlarged left supraclavicular node (Virchow node), and is considered a sign of metastatic abdominal malignancy. It is sometimes referred to as Virchow node, which is the name given by Dr Rudolf Virchow (1821-1902), a German pathologist, The left supraclavicular lymph node drains via the thoracic duct, the abdomen, and thorax. It is the junction where incoming lymph is introduced back in the venous circulation through the left subclavian vein. Hence, any malignancy arising in these territories can be responsible for Troisier sign. Krukenberg tumour, also known as carcinoma mucocellulare, refers to the "signet ring" subtype of metastatic tumour to the ovary. The colon and stomach are the most common primary tumours to result in ovarian metastases, followed by the breast, lung, and contralateral ovary. The tumours represent 5-10% of all ovarian tumours and up to 50% of all metastatic tumours to the ovary. Krukenberg tumours are metastatic tumours to the ovary that contain well defined histological characteristics - mucin-secreting “signet ring” cells and usually originate in the gastrointestinal tract 1 They can originate from : stomach cancer (signet-ring cells): most common colorectal carcinoma: second most common breast cancer lung cancer contralateral ovarian carcinoma pancreatic carcinoma cholangiocarcionoma/gallbladder carcinoma Most imaging features are non-specific, consisting of predominantly solid components or a mixture of cystic and solid areas. It is often difficult to differentiate from other ovarian neoplasms 4-5. There are a variety of metastatic carcinomas to the ovary that can mimic primary ovarian tumour These tumour are typically seen sonographically as bilateral, solid ovarian masses, with clear well defined margins. CT appearances can be indistinguishable from primary ovarian carcinoma 2. Features will favour towards a Krukenberg tumour if a concurrent gastric or colic mural lesion is seen. MR: The great majority of Krukenberg tumours are signet-ring cell carcinomas arising in the stomach. Signet- ring cells scatter in the ovarian stroma with abundant collagen formation or marked oedema. Therefore, Krukenberg tumours can occasionally show low or high signal intensity on T2-weighted images. internal hyperintensity (mucin) on T1 and T2 weighted MR images. Strong contrast enhancement is usually seen in the solid component or the wall of the intratumoural cys Follow-up CT in known peritoneal carcinosis from resected colon cancer. Solid mass of the left ovary. Coronal T2 Axial T1 Axial T2 Both ovaries are replaced by lobulated, well defined, heterogeneously high T2, enhancing lesions. Moderate volume ascites see in the pelvis. pathologically proven Krukenberg tumour of gastric origin. Axial T1, contrast fat sat Sag T2 Irregular stenosis with rigidity of the greater curvature of the stomach at prepyloric gastric antrum 66 years-old man who presented with general decline in health & epigastric heaviness an intra-luminal hypodense and heteregeneous mass. Also, there is a triangular hypodensity involving the upper pole of the spleen. (splenic artery thrombosis secondary to this infiltration) Case 2 Patient Data Male 47 years complaining Difficulty in swallowing liquids. Mediastinal widening. Trace amount of gastric air bubble seen. No air-fluid level in the mediastinal widening can be appreciated. Dysphagia and recurrent chest infection. Male, 40 years Chest x-ray is largely unremarkabl e. Minor patchy opacities in the left base are noted. A small gastric air bubble is visible. Upper GI study reveals uniform dilatation of the esophagus to the level of the gastroesophageal junction, where fixed narrowing is noted (bird peak sign or rat-tail sign) Case 3 C/O: Recurrent chest infection Note oesophageal dilatation CT scan of the abdomen showed uniform dilatation of esophagus with air-fluid level. Pulmonary infiltrates in the upper segment of the right lower lobe likely due to aspiration Achalasia (primary achalasia) refers to a failure of organised oesophageal peristalsis with an impaired relaxation of the lower oesophageal sphincter (LOS), resulting in often marked dilatation of the oesophagus and food stasis. Obstruction of the distal oesophagus (often due to tumour) has been termed "secondary achalasia" or "pseudoachalasia". Primary achalasia is most frequently seen in middle and late adulthood (30-70 years of age) with no gender predilection 6. In most cases achalasia is idiopathic; however, an identical appearance is seen in patients with Chagas disease. Authors differ as to whether they reserve the term achalasia for idiopathic cases, or whether they include Chagas disease. Typically patients present with dysphagia (which is for both solids and liquids, in comparison to
Recommended publications
  • Klatskin Tumors and “Klatskin-Mimicking Lesions”: Our 22- Year Experience
    Title: Klatskin tumors and “Klatskin-mimicking lesions”: our 22- year experience. Authors: Konstantinos Tsalis, Styliani Parpoudi, Dimitrios Kyziridis, Orestis Ioannidis, Natalia Antigoni Savvala, Nikolaos Antoniou, Savvas Symeonidis, Dimitrios Konstantaras, Ioannis Mantzoros, Manousos-Georgios Pramateftakis, Efstathios Kotidis, Stamatios Angelopoulos DOI: 10.17235/reed.2018.5749/2018 Link: PubMed (Epub ahead of print) Please cite this article as: Tsalis Konstantinos, Parpoudi Styliani, Kyziridis Dimitrios, Ioannidis Orestis, Savvala Natalia Antigoni , Antoniou Nikolaos , Symeonidis Savvas, Konstantaras Dimitrios , Mantzoros Ioannis, Pramateftakis Manousos-Georgios, Kotidis Efstathios, Angelopoulos Stamatios. Klatskin tumors and “Klatskin-mimicking lesions”: our 22-year experience. Rev Esp Enferm Dig 2018. doi: 10.17235/reed.2018.5749/2018. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. OR 5749 Klatskin tumors and “Klatskin-mimicking lesions”: our 22-year experience Konstantinos Tsalis, Styliani Parpoudi, Dimitrios Kyziridis, Orestis Ioannidis, Natalia Antigoni-Savvala, Nikolaos Antoniou, Savvas Symeonidis, Dimitrios Konstantaras, Ioannis Mantzoros, Pramateftakis Manousos-George, Kotidis Efstathios and Stamatios Angelopoulos Fourth Surgical Department. Medical School. Aristotle University of Thessaloniki. Thessaloniki, Greece. General Hospital “George Papanikoalou”. Thessaloniki, Greece Received: 04/06/2018 Accepted: 04/09/2018 Correspondence: Orestis Ioannidis. Fourth Surgical Department. Medical School. Aristotle University of Thessaloniki. Thessaloniki, Greece. General Hospital “G.
    [Show full text]
  • Case Report Primary Neuroendocrine Tumor of the Left Hepatic Duct: a Case Report with Review of the Literature
    Hindawi Publishing Corporation Case Reports in Surgery Volume 2012, Article ID 786432, 7 pages doi:10.1155/2012/786432 Case Report Primary Neuroendocrine Tumor of the Left Hepatic Duct: A Case Report with Review of the Literature Ajay H. Bhandarwar, Taher A. Shaikh, Ashok D. Borisa, Jaydeep H. Palep, Arun S. Patil, and Aditya A. Manke Division of GI and HPP Surgery, Department of Surgery, Grant Medical College & Sir JJ Group of Hospitals, Byculla, Mumbai 400008, India Correspondence should be addressed to Ajay H. Bhandarwar, [email protected] Received 29 April 2012; Accepted 29 August 2012 Academic Editors: T. C¸ olak and M. Ganau Copyright © 2012 Ajay H. Bhandarwar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Primary Biliary Tract Neuroendocrine tumors (NET) are extremely rare tumors with only 77 cases been reported in the literature till now. We describe a case of a left hepatic duct NET and review the literature for this rare malignancy. To the best of our knowledge the present case is the first reported case of a left hepatic duct NET in the literature. In spite of availability of advanced diagnostic tools like Computerized Tomography (CT) Scan and Endoscopic Retrograde Cholangio Pancreaticography (ERCP) a definitive diagnosis of these tumors is possible only after an accurate histopathologic diagnosis of operative specimens with immunohistochemistry and electron microscopy. Though surgical excision remains the gold standard treatment for such tumors, patients with unresectable tumors have good survival with newer biologic agents like Octreotride.
    [Show full text]
  • NCCN Guidelines for Patients Gallbladder and Bile Duct Cancers
    NCCN GUIDELINES FOR PATIENTS® 2021 Gallbladder and Bile Duct Cancers Hepatobiliary Cancers Presented with support from: Available online at NCCN.org/patients Ü Gallbladder and Bile Duct Cancers It's easy to get lost in the cancer world Let Ü NCCN Guidelines for Patients® be your guide 9 Step-by-step guides to the cancer care options likely to have the best results 9 Based on treatment guidelines used by health care providers worldwide 9 Designed to help you discuss cancer treatment with your doctors NCCN Guidelines for Patients® Gallbladder and Bile Duct Cancers, 2021 1 About National Comprehensive Cancer Network® NCCN Guidelines for Patients® are developed by the National Comprehensive Cancer Network® (NCCN®) NCCN Clinical Practice NCCN Guidelines NCCN Ü Ü Guidelines in Oncology for Patients (NCCN Guidelines®) 9 An alliance of leading 9 Developed by doctors from 9 Present information from the cancer centers across the NCCN cancer centers using NCCN Guidelines in an easy- United States devoted to the latest research and years to-learn format patient care, research, and of experience 9 For people with cancer and education 9 For providers of cancer care those who support them all over the world Cancer centers 9 Explain the cancer care that are part of NCCN: 9 Expert recommendations for options likely to have the NCCN.org/cancercenters cancer screening, diagnosis, best results and treatment Free online at Free online at NCCN.org/patientguidelines NCCN.org/guidelines and supported by funding from NCCN Foundation® These NCCN Guidelines for Patients are based on the NCCN Guidelines® for Hepatobiliary Cancers (Version 3.2021, June 15, 2021).
    [Show full text]
  • New Jersey State Cancer Registry List of Reportable Diseases and Conditions Effective Date March 10, 2011; Revised March 2019
    New Jersey State Cancer Registry List of reportable diseases and conditions Effective date March 10, 2011; Revised March 2019 General Rules for Reportability (a) If a diagnosis includes any of the following words, every New Jersey health care facility, physician, dentist, other health care provider or independent clinical laboratory shall report the case to the Department in accordance with the provisions of N.J.A.C. 8:57A. Cancer; Carcinoma; Adenocarcinoma; Carcinoid tumor; Leukemia; Lymphoma; Malignant; and/or Sarcoma (b) Every New Jersey health care facility, physician, dentist, other health care provider or independent clinical laboratory shall report any case having a diagnosis listed at (g) below and which contains any of the following terms in the final diagnosis to the Department in accordance with the provisions of N.J.A.C. 8:57A. Apparent(ly); Appears; Compatible/Compatible with; Consistent with; Favors; Malignant appearing; Most likely; Presumed; Probable; Suspect(ed); Suspicious (for); and/or Typical (of) (c) Basal cell carcinomas and squamous cell carcinomas of the skin are NOT reportable, except when they are diagnosed in the labia, clitoris, vulva, prepuce, penis or scrotum. (d) Carcinoma in situ of the cervix and/or cervical squamous intraepithelial neoplasia III (CIN III) are NOT reportable. (e) Insofar as soft tissue tumors can arise in almost any body site, the primary site of the soft tissue tumor shall also be examined for any questionable neoplasm. NJSCR REPORTABILITY LIST – 2019 1 (f) If any uncertainty regarding the reporting of a particular case exists, the health care facility, physician, dentist, other health care provider or independent clinical laboratory shall contact the Department for guidance at (609) 633‐0500 or view information on the following website http://www.nj.gov/health/ces/njscr.shtml.
    [Show full text]
  • Letters to the Editor EXTRAHEPATIC BILIARY
    ABCDDV/904 ABCD Arq Bras Cir Dig Carta ao Editor 2013;26(1):66-68 CISTOADENOCARCINOMA BILIAR EXTRA-HEPÁTICO MIMETIZANDO TUMOR DE KLATSKIN Extrahepatic biliary cystadenocarcinoma mimicking Klatskin tumor Sergio Renato PAIS-COSTA, Sandro Jose MARTINS, Sergio Luiz Melo ARAUJO, Olímpia Alves Teixeira LIMA, Marcio Almeida PAES, Marcio Lobo GUIMARAES Trabalho realizado no Hospital Santa Lucia, Brasília, DF, Brasil. estava elevado com 345 U/l. O paciente foi submetido à tomografia computadorizada, que mostrou lesão Correspondência: Sergio Renato Pais Costa, cística com irregularidade e parede espessa com dutos e-mail [email protected] biliares intra-hepáticos dilatados principalmente do lado esquerdo e atrofia do lobo esquerdo. Foi submetido à Fonte de financiamento: não há colangioressonância que mostrou dilatação da árvore Conflito de interesses: não há biliar intra-hepática mais significativa no lado esquerdo, Recebido para publicação: 26/08/2011 ducto biliar com irregularidade e com parede mais Aceito para publicação: 22/08/2012 espessada perto de confluência hepática (Figura 1). O paciente foi submetido a exame radiológico sem sinais INTRODUÇÃO de disseminação sistêmica. O diagnóstico inicial era colangiocarcinoma hilar ou cistoadenoma extra biliar ou istadenocarcinoma biliar (BCAC) é uma rara cistoadenocarcinoma. Foi indicado tratamento cirúrgico, neoplasia maligna cística. Alguns autores com ressecção da árvore biliar suprapancreática incluindo Cpensam ser ela a conversão de cistoadenoma confluência hilar e hepatectomia em bloco estendida à biliar de longa evolução. Na maioria dos casos ocorre esquerda com lobectomia caudada. Linfadenectomia no parênquima (cistadenocarcinoma intra-hepático); hilar foi também realizada durante a ressecção cirúrgica por vezes, pode ser observado com origem biliar extra- (Figura 2).
    [Show full text]
  • Hilar Cholangiocarcinoma (Klatskin Tumor)
    Clinical problem Hilar Cholangiocarcinoma (Klatskin tumor) Rodrigo Castaño Llano, MD.1 1 Gastrointestinal Surgeon and Endoscopist. Professor Abstract in the Gastro-hepatology group at the Universidad de Antioquia. Professor of Surgery at the Universidad This is a clinical case of a 71-year-old man with an obstructive lesion of the hepatic hilum, the clinical, imaging Pontificia Bolivariana. Hospital Pablo Tobón Uribe. studies and the lab tests suggest a Klatskin tumor, which was managed by percutaneous biliary drainage to Medellin, Colombia relieve the jaundice. In this review we consider the pathogenetic factors of these tumors, a new anatomic ......................................... classifi cation and the various alternative imaging studies, emphasizing the Bismuth-Corlette classifi cation. Received: 23-05-11 Confront palliative alternatives, such as different types of endoscopic stents or percutaneous approach, drai- Accepted: 01-06-11 nage extension (uni or bilateral). Finally, we review the surgical aspects and possibilities of chemotherapy and radiotherapy in these tumors. Key words Hilar cholangiocarcinoma, endoscopic retrograde cholangiography, nuclear magnetic resonance cholangiog- raphy, hepatobiliary surgery. CLINICAL CASE Alanine aminotransferase (ALT) 92 U/L, Amylase 62 mg/ dl, direct bilirubin 16 mg/dl, total bilirubin 22.8 mg/dl and A 71 year old male patient consulted aft er one month of alkaline phosphatase 253 U/L. suff ering right upper quadrant pain associated with acholia, In hepatobiliary ultrasound images the liver appeared choluria and generalized jaundice with episodes of subjec- heterogeneous and oversized with intrahepatic and extra- tive fever. hepatic biliary ducts dilated to 13 mm. In addition the Important antecedents included arterial hypertension sonography showed that the patient suff ered from post- and an open cholecystectomy 9 years earlier.
    [Show full text]
  • Effective for Cases Diagnosed January 1, 2016 and Later
    POLICY AND PROCEDURE MANUAL FOR REPORTING FACILITIES May 2016 Effective For Cases Diagnosed January 1, 2016 and Later Indiana State Cancer Registry Indiana State Department of Health 2 North Meridian Street, Section 6-B Indianapolis, IN 46204-3010 TABLE OF CONTENTS INDIANA STATE DEPARTMENT OF HEALTH STAFF ............................................................................. viii INDIANA STATE DEPARTMENT OF HEALTH CANCER REGISTRY STAFF .......................................... ix ACKNOWLEDGMENTS ................................................................................................................................ x INTRODUCTION ........................................................................................................................................... 1 A. Background ..................................................................................................................................... 1 B. Purpose .......................................................................................................................................... 1 C. Definitions ....................................................................................................................................... 1 D. Reference Materials........................................................................................................................ 1 E. Consultation .................................................................................................................................... 2 F. Output ............................................................................................................................................
    [Show full text]
  • Management of Neuroendocrine Tumors of the Extrahepatic Bile Duct: Case Report and Review of the Literature
    www.jcimcr.org Journal of Clinical Images and Medical Case Reports ISSN 2766-7820 Case Report Open Access, Volume 2 Management of neuroendocrine tumors of the extrahepatic bile duct: Case report and review of the literature Luca Portigliotti1*; Fabio Maroso1; Andrea Amabile1; Filadelfio Massimiliano Nicolosi1; Fabio Colli1; Fabio Frosio1; Oscar Soresini1; Nicola de’Angelis2; Renzo Luciano Boldorini3; Raffaele Romito1 1General Surgery Department, A.O.U. “Maggiore della Carità” Hospital, Novara, Italy. 2Minimally Invasive and Robotic Digestive Surgery Unit, Regional General Hospital F. Miulli, Acquaviva delle Fonti (Bari), Italy and University Paris Est - UPEC, France. 3Department of Health Science, School of Medicine, University of Eastern Piedmont “Amedeo Avogadro”. Pathology Unit, “Mag- giore della Carità” Hospital. Abstract *Corresponding Authors: Luca Portigliotti General Surgery Department, A.O.U. “Maggiore Neuroendocrine tumors of the extrahepatic bile duct (EBNETs) della Carità” Hospital, Corso Mazzini 18, 28100, are exceedingly rare neoplasms, whose diagnostic and therapeutic Novara, Italy. process can be challenging. We present the case of a 58-year-old EBNET patient successfully treated at our Institution, followed by a Tel +393474474903, Fax: +39 03213733338; systematic review of the literature on the surgical management of Email: [email protected] these rare tumors. Received: July 01, 2021 Keywords: neuroendocrine tumor; biliary neoplasm; carcinoid; bili- Accepted: Aug 09, 2021 ary tract obstruction. Published:
    [Show full text]
  • Bilateral Ovarian Metastasis of a Klatskin Tumor: a Rare Case Klatskin Tümörünün Bilateral Ovarian Metastazı: Nadir Bir Olgu
    Case Report / Olgu Sunumu DOI: 10.4274/tjod.40222 Turk J Obstet Gynecol 2016;13:215-7 Bilateral ovarian metastasis of a Klatskin tumor: A rare case Klatskin tümörünün bilateral ovarian metastazı: Nadir bir olgu Sefa Kurt1, Çağnur Ulukuş2, Seher Nazlı Kazaz3, İbrahim Astarcıoğlu4 1Dokuz Eylül University Faculty of Medicine, Department of Obstetrics and Gynecology, İzmir, Turkey 2Dokuz Eylül University Faculty of Medicine, Department of Pathology, İzmir, Turkey 3Dokuz Eylül University Faculty of Medicine, Department of Internal Medicine, Division of Medical Oncology, İzmir, Turkey 4Dokuz Eylül University Faculty of Medicine, Department of General Surgery, İzmir, Turkey Abstract Metastatic carcinomas of the ovary have an important place in all ovarian cancers and tumors. They can originate from many organs and systems and may metastasize to the ovary. The most common primary origin of metastasis is the gastrointestinal tract and then breast tissue. Cholangiocellular carcinomas involving the junction of the right and left bile ducts are called Klatskin tumors, and their metastases to the ovaries are very rare. A woman aged 54 years who had been treated previously for Klatskin tumor was admitted to our clinic due to bilateral ovarian masses and high serum calcium 19-9 levels. The preoperative approach, operative, and postoperative management of Klatskin tumor is presented. Keywords: Klatskin tumor, metastatic ovarian tumor, cholangiocellular carcinoma Öz Metastatik over kanserleri tüm over kanserleri içinde önemli bir yere sahiptir. Overe bir çok sistem ve organdan metastaz olabilmektedir. Metastazın en sık primer orijini gastrointestinal sistemdir ve bunu meme izler. Sağ ve sol safra kanallarının kavşağını kapsayan kolanjiosellüler karsinomlara Klatskin tümörü denir ve overlere metastazı çok nadir görülür.
    [Show full text]
  • Personal Experience with 411 Hepatic Resections
    Reprinted from ANNALS of SURGERY, Vol. 208, No.4, October 1988. Copyright, © 1988, by 1. B. Lippincott Company. Printed in U.S.A. Personal Experience With 411 Hepatic Resections SHUNZABURO IWATSUKI, M.D. and THOMAS E. STARZL, M.D., PH.D. Over a 24-year period, 411 partial hepatic resections were per­ From the Department of Surgery, University Health Center of formed: 142 right or left trisegmentectomies, 158 lobectomies, Pittsburgh, University of Pittsburgh, and the Veterans 25 segmentectomies, and 86 local excisions. The operations were Administration Medical Center, Pittsburgh, Pennsylvania performed for benign lesions in 182 patients, for primary hepatic malignancies in 106, and for hepatic metastases in 123, including 90 from colorectal cancers. The 30-day (operative) mortality rate became feasible. 2- 7 Almost two more decades ensued be­ was 3.2%, and there were an additional six late deaths (1.5%) fore hepatic resections could be performed safely by many due to hepatic failure caused by the resection. The highest op­ surgical specialists interested in this field. erative mortality rate (6.3%) resulted from the trisegmentecto­ mies, but this Iperely reflected the extent of the disease being Our interest in hepatic resection started with the referral treated. A mortality rate of8.5% for patients with primary hepatic of patients for liver transplantation whose hepatic lesions malignancy was associated not only with the extensiveness of were believed to be too extensive for subtotal hepatectomy. lesions, but also with cirrhosis in the remaining liver fragment. Many such masses could be resected with modifications There was no mortality for 123 patients with metastatic disease, of previously described but uncommonly used operations, 100 patients with cavernous hemangioma, 22 with liver cell ad­ enoma, 17 with focal nodular hyperplasia, 16 with congenital such as right trisegmentectomy,8,9 or with operations not cystic disease, and five with hydatid cysts.
    [Show full text]
  • Neuroendocrine Tumour of the Main Bile Duct: Case Report and Review of Literature
    Case Report A rare cause of recurrent cholangitis: neuroendocrine tumour of the main bile duct: case report and review of literature Bert Deylgat1, Sarah Vandenhaute1, Vincent De Wilde2, Ivo Van Den Berghe3, Tom Feryn1 1Department of General, Pediatric and Vascular Surgery, 2Department of Gastro-Enterology, 3Department of Pathology, AZ Sint-Jan Brugge Oostende AV, Belgium Correspondence to: Sarah Vandenhaute. AZ Sint-Jan Brugge Oostende AV, Ruddershove 10, 8000 Brugge, Belgium. Email: [email protected]. Background: Neuro-endocrine neoplasms (NEN’s), formerly called “carcinoids”, appear to be a heterogeneous group of tumours varying in location, size and clinical symptoms. Given the difference in functional and biological behaviour, the World Health Organization (WHO) established criteria to classify NEN’s irrespective of their site of origin, which could predict the biological behaviour with high probability. Methods: We present the case of a 75-year-old female patient with recurrent cholangitis, itching and limited weight loss. After diagnostic work up, a solid mass obstructing the common bile duct (CBD) was found. Since no distant metastases were seen, resection was decided upon with hepaticojejunostomy and Roux-en Y reconstruction. The pathology report showed a neuro-endocrine neoplasm (NEN) of the extrahepatic bile duct (EHBD). Results: NEN’s are an exceptional cause of conjugated hyperbilirubinemia in the presence of dilated intra- and extra-hepatic bile ducts. If one suspects an intrinsic tumour of the extra-hepatic bile duct, a cholangiocarcinoma accounts for 80-90%. NEN’s of the EHBD appear to have a more indolent biologic evolution than cholangiocarcinomas. However, a preoperative differentiation is often difficult, as NEN’s are located in the submucosa and endoscopic brush cytology has a low sensitivity.
    [Show full text]
  • Challenges in Treatment of a Patient Suffering from Neuroendocrine Tumor G1 of the Hilar Bile Duct: a Case Report
    Challenges in treatment of a patient suffering from neuroendocrine tumor G1 of the hilar bile duct: a case report Biao Zhang Dalian Medical University Zhen Sun Dalian Medical University Xu Chen Dalian Medical University Bing Qi Dalian Medical University Qingkai Zhang Dalian Medical University Guixin Zhang Dalian Medical University Shuang Li ( [email protected] ) Dong Shang Dalian Medical University Case report Keywords: Biliary neuroendocrine tumors, Diagnosis, Treatment, R1 resection, Case report Posted Date: April 1st, 2021 DOI: https://doi.org/10.21203/rs.3.rs-377428/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/12 Abstract Background Neuroendocrine tumors (NETs) arise from neuroendocrine cells and are extremely rare located in the biliary tract. Currently, there are no guidelines for the diagnosis and treatment of biliary NETs. We present a case with NETs G1 of the hilar bile duct and the challenges for her treatment. Case presentation A 24-year-old woman was presented to our department with painless jaundice and pruritus, and the preoperative diagnosis was the perihilar bile duct cholangiocarcinoma. She underwent Roux-en-Y hepaticojejunostomy with excision of the extrahepatic biliary tree and radical lymphadenectomy. Unexpectedly, postoperative pathology showed a perihilar bile duct NETs G1 and microscopic invasion of the resected right hepatic duct. Then the patient received 3 cycles of adjuvant chemotherapy (Gemcitabine and tegafur-gimeracil-oteracil potassium capsule). At present, this patient has been following up for 20 months without recurrence or disease progression. Conclusions NETs of the biliary tract are dicult to diagnose preoperatively.
    [Show full text]